Literature DB >> 28363601

Methylglyoxal-induced AMPK activation leads to autophagic degradation of thioredoxin 1 and glyoxalase 2 in HT22 nerve cells.

Alcir Luiz Dafre1, Ariana Ern Schmitz2, Pamela Maher3.   

Abstract

Methylglyoxal (MGO) is a major glycating agent that reacts with basic residues of proteins and promotes the formation of advanced glycation end products which are believed to play key roles in a number of pathologies, such as diabetes, Alzheimer's disease, and inflammation. We previously showed that MGO treatment targets the thioredoxin and the glyoxalase systems, leading to a decrease in Trx1 and Glo2 proteins in immortalized mouse hippocampal HT22 nerve cells. Here, we propose that autophagy is the underlying mechanism leading to Glo2 and Trx1 loss induced by MGO. The autophagic markers p62, and the lipidated and active form of LC3, were increased by MGO (0.5mM). Autophagy inhibition with bafilomycin or chloroquine prevented the decrease in Trx1 and Glo2 at 6 and 18h after MGO treatment. Proteasome inhibition by MG132 exacerbated the effect of MGO on Trx1 and Glo2 degradation (18h), further suggesting a role for autophagy. ATG5 small interfering RNA protected Trx1 and Glo2 from MGO-induced degradation, confirming Trx1 and Glo2 loss is mediated by autophagy. In the search for the signals that control autophagy, we found that AMPK activation, a known autophagy inducer, was markedly increased by MGO treatment. AMPK activation was confirmed by increased acetyl coenzyme A carboxylase phosphorylation, a direct AMPK substrate and by decreased mTOR phosphorylation, an indirect marker of AMPK activation. To confirm that MGO-mediated Trx1 and Glo2 degradation was AMPK-dependent, AMPK-deficient mouse embryonic fibroblasts (MEFs) were treated with MGO. Wildtype MEFs presented the expected decrease in Trx1 and Glo2, while MGO was ineffective in decreasing these proteins in AMPK-deficient cells. Overall, the data indicate that MGO activates autophagy in an AMPK-dependent manner, and that autophagy was responsible for Trx1 and Glo2 degradation, confirming that Trx1 and Glo2 are molecular targets of MGO.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMPK, mTOR; Autophagy; Glyoxalase; HT22 cells; Methylglyoxal; Thioredoxin

Mesh:

Substances:

Year:  2017        PMID: 28363601      PMCID: PMC5492945          DOI: 10.1016/j.freeradbiomed.2017.03.028

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  52 in total

1.  Proteasome inhibition in glyoxal-treated fibroblasts and resistance of glycated glucose-6-phosphate dehydrogenase to 20 S proteasome degradation in vitro.

Authors:  A L Bulteau; P Verbeke; I Petropoulos; A F Chaffotte; B Friguet
Journal:  J Biol Chem       Date:  2001-09-14       Impact factor: 5.157

Review 2.  Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases.

Authors:  M A Grillo; S Colombatto
Journal:  Amino Acids       Date:  2007-11-16       Impact factor: 3.520

Review 3.  Reversible cysteine oxidation in hydrogen peroxide sensing and signal transduction.

Authors:  Sarela García-Santamarina; Susanna Boronat; Elena Hidalgo
Journal:  Biochemistry       Date:  2014-04-16       Impact factor: 3.162

Review 4.  Autophagy in kidney disease and aging: lessons from rodent models.

Authors:  Olivia Lenoir; Pierre-Louis Tharaux; Tobias B Huber
Journal:  Kidney Int       Date:  2016-06-18       Impact factor: 10.612

Review 5.  Reactivity of thioredoxin as a protein thiol-disulfide oxidoreductase.

Authors:  Zhiyong Cheng; Jinfeng Zhang; David P Ballou; Charles H Williams
Journal:  Chem Rev       Date:  2011-07-27       Impact factor: 60.622

6.  Methylglyoxal has deleterious effects on thioredoxin in human aortic endothelial cells.

Authors:  Tatsuya Oba; Ryosuke Tatsunami; Keisuke Sato; Kyohei Takahashi; Zhihui Hao; Yoshiko Tampo
Journal:  Environ Toxicol Pharmacol       Date:  2012-03-20       Impact factor: 4.860

7.  Induction of autophagy by the MG‑132 proteasome inhibitor is associated with endoplasmic reticulum stress in MCF‑7 cells.

Authors:  Wenhua Bao; Yiqi Gu; La Ta; Keren Wang; Zheli Xu
Journal:  Mol Med Rep       Date:  2015-11-23       Impact factor: 2.952

8.  Angiogenesis impairment in diabetes: role of methylglyoxal-induced receptor for advanced glycation endproducts, autophagy and vascular endothelial growth factor receptor 2.

Authors:  Hongtao Liu; Shujie Yu; Hua Zhang; Jian Xu
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

Review 9.  Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics.

Authors:  Naila Rabbani; Mingzhan Xue; Paul J Thornalley
Journal:  Glycoconj J       Date:  2016-07-12       Impact factor: 2.916

Review 10.  The role of the selective adaptor p62 and ubiquitin-like proteins in autophagy.

Authors:  Mónika Lippai; Péter Lőw
Journal:  Biomed Res Int       Date:  2014-06-12       Impact factor: 3.411

View more
  9 in total

1.  Methylglyoxal-Induced Protection Response and Toxicity: Role of Glutathione Reductase and Thioredoxin Systems.

Authors:  Ariana Ern Schmitz; Luiz Felipe de Souza; Barbara Dos Santos; Pamela Maher; Fernanda Martins Lopes; Giovana Ferreira Londero; Fabio Klamt; Alcir Luiz Dafre
Journal:  Neurotox Res       Date:  2017-05-06       Impact factor: 3.911

2.  Hyperosmotic Stress Initiates AMPK-Independent Autophagy and AMPK- and Autophagy-Independent Depletion of Thioredoxin 1 and Glyoxalase 2 in HT22 Nerve Cells.

Authors:  Alcir Luiz Dafre; Ariana Ern Schmitz; Pamela Maher
Journal:  Oxid Med Cell Longev       Date:  2019-03-27       Impact factor: 6.543

3.  Methylglyoxal-Mediated Dopamine Depletion, Working Memory Deficit, and Depression-Like Behavior Are Prevented by a Dopamine/Noradrenaline Reuptake Inhibitor.

Authors:  Gudrian Ricardo Lopes de Almeida; Jozimar Carlos Szczepanik; Ingrid Selhorst; Ariana Ern Schmitz; Bárbara Dos Santos; Maurício Peña Cunha; Isabella Aparecida Heinrich; Gabriela Cristina de Paula; Andreza Fabro De Bem; Rodrigo Bainy Leal; Alcir Luiz Dafre
Journal:  Mol Neurobiol       Date:  2020-10-04       Impact factor: 5.590

4.  Defining a pharmacological inhibitor fingerprint for oxytosis/ferroptosis.

Authors:  David Soriano-Castell; Antonio Currais; Pamela Maher
Journal:  Free Radic Biol Med       Date:  2021-05-16       Impact factor: 8.101

5.  Autophagy Functions to Prevent Methylglyoxal-Induced Apoptosis in HK-2 Cells.

Authors:  So-Hyun Park; Hyun-Il Choi; Jiyun Ahn; Young-Jin Jang; Tae-Youl Ha; Hyo-Deok Seo; Yoon-Sook Kim; Dae-Hee Lee; Chang Hwa Jung
Journal:  Oxid Med Cell Longev       Date:  2020-06-04       Impact factor: 6.543

6.  Methylglyoxal down-regulates the expression of cell cycle associated genes and activates the p53 pathway in human umbilical vein endothelial cells.

Authors:  Jana D Braun; Diego O Pastene; Annette Breedijk; Angelica Rodriguez; Björn B Hofmann; Carsten Sticht; Elke von Ochsenstein; Heike Allgayer; Jacob van den Born; Stephan Bakker; Sibylle J Hauske; Bernhard K Krämer; Benito A Yard; Thomas Albrecht
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

Review 7.  Prospects of honey in fighting against COVID-19: pharmacological insights and therapeutic promises.

Authors:  Khandkar Shaharina Hossain; Md Golzar Hossain; Akhi Moni; Md Mahbubur Rahman; Umma Habiba Rahman; Mohaimanul Alam; Sushmita Kundu; Md Masudur Rahman; Md Abdul Hannan; Md Jamal Uddin
Journal:  Heliyon       Date:  2020-12-21

8.  Methylglyoxal induces p53 activation and inhibits mTORC1 in human umbilical vein endothelial cells.

Authors:  Xinmiao Zhang; Angelica Rodriguez-Niño; Diego O Pastene; Prama Pallavi; Jacob van den Born; Stephan J L Bakker; Bernhard K Krämer; Benito A Yard
Journal:  Sci Rep       Date:  2021-04-13       Impact factor: 4.379

9.  Downregulation of the Glo1 Gene Is Associated with Reduced Adiposity and Ectopic Fat Accumulation in Spontaneously Hypertensive Rats.

Authors:  Jan Šilhavý; Hana Malínská; Martina Hüttl; Irena Marková; Olena Oliyarnyk; Petr Mlejnek; Miroslava Šimáková; František Liška; Ludmila Kazdová; Radka Moravcová; Jiří Novotný; Michal Pravenec
Journal:  Antioxidants (Basel)       Date:  2020-11-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.